DANIEL WADDELL: Open Payments
NPI 1427628098 · LIBERTY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,990 in 88 payments from 20 companies in 2025. Trend: 2023 $22 · 2024 $984 · 2025 $1,990
Food & beverage: $1,990
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $376 |
| ABBVIE INC. | 16 | $299 |
| Lilly USA, LLC | 7 | $230 |
| AstraZeneca Pharmaceuticals LP | 8 | $176 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $145 |
| PFIZER INC. | 7 | $137 |
| GlaxoSmithKline, LLC. | 3 | $110 |
| Axsome Therapeutics, Inc. | 5 | $91 |
| Grifols USA, LLC | 4 | $89 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
Products named: Wegovy, VRAYLAR, Kerendia, AIRSUPRA, ZEPBOUND, MOUNJARO, Auvelity, Prolastin-C Liquid.
Industry payments across NC — which companies pay providers there.
